First drug to treat wintertime blues approved
Antidepressant OK'd for preventing seasonal affective disorder
INTERACTIVE |
Mental health videos |
Loneliness may be contagious Dec. 1: New study finds that the feeling of loneliness may spread like a cold. Dr. Nancy Snyderman gives her take on this study and more in “The Spin Doctor.” |
updated 3:32 p.m. ET June 12, 2006
WASHINGTON - An antidepressant won federal approval Monday as the first drug to treat seasonal affective disorder, the wintertime blues that can strike when the days grow short.
Wellbutrin XL can be used in the prevention of major depressive episodes in patients with a history of seasonal affective disorder, often called SAD, the Food and Drug Administration said.
SAD is characterized by recurrent major depressive episodes during the fall and winter.
The FDA approved Wellbutrin XL — the extended release version of bupropion HCL in tablet form — in 2003. The original version of the drug won approval in 1985.
Wellbutrin XL is manufactured by GlaxoSmithKline.
© 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- Discuss Story On Newsvine
-
Rate Story:
View popularLowHigh - Instant Message
MORE FROM MENTAL HEALTH |
| Add Mental health headlines to your news reader: |
Resource guide


